TrialBlood cancer journal2019

A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma.

Andrew Spencer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.